Healio OSN: accelerated CXL for thin corneas

Corneal cross-linking is the main way doctors try to stop keratoconus from getting worse. The problem is that the standard version has a hard safety cutoff — if the cornea is too thin, UV treatment can threaten the endothelium, the cell layer at the back that the eye really cannot afford to lose. That leaves some of the highest-risk patients in a bad spot. (healio.com) The news here is that a newer accelerated approach, using hypo-osmolar riboflavin to temporarily swell the cornea, looked workable in thin corneas in a 76-eye study that Healio highlighted on May 8. ### What is keratoconus, exactly? Keratoconus is a corneal ectasia — basically the cornea gets weaker, thins, and bulges forward into a cone-like shape. That distorts vision and can keep getting worse, especially in younger patients. (healio.com) Glasses stop being enough. Contacts can become hard to tolerate. In advanced cases, people can end up needing a transplant. ### Why does thinness make cross-linking tricky? Standard epithelium-off cross-linking was built around a safety threshold of about 400 µm. That number matters because the UV light and riboflavin reaction should stiffen the front part of the cornea without damaging deeper tissue. If the cornea is too thin, the protective margin shrinks, and the endothelial cells become the concern. Those cells do not regenerate in any meaningful way. (healio.com) ### So what changed in this protocol? The trick is the riboflavin solution. A hypo-osmolar formula — listed here as 300 mOsmol/L and without dextran — pulls water into the cornea and makes the stroma swell temporarily. That can push a borderline cornea above the treatment threshold long enough to do the UV step more safely. It is not rebuilding tissue. (pubmed.ncbi.nlm.nih.gov) It is creating a short-lived safety cushion. ### What did the new study actually test? The Journal of Refractive Surgery paper looked at 76 eyes from 69 patients with progressive keratoconus who underwent accelerated cross-linking with hypo-osmolar riboflavin. The researchers split eyes by intraoperative corneal thickness — thinner than 400 µm versus 400 µm or thicker — and tracked endothelial cell density, vision, refraction, topography, and higher-order aberrations out to 12 months. (healio.com) ### Did it seem to work? Broadly, yes. Both groups improved in uncorrected and corrected distance visual acuity by 12 months, and there was no meaningful difference between thin and thicker corneas on that front. The thinner-than-400 µm group also showed a significant drop in maximum keratometry, which is a useful sign because steeper corneas usually mean more advanced ectasia. The thicker group was mostly stable rather than dramatically flatter. (healio.com) ### What about safety? This is the key part. Neither group had a significant drop in endothelial cell density at 12 months, which is exactly the complication surgeons worry about in very thin corneas. Higher-order aberrations also did not change significantly. There was a catch, though — four patients developed permanent corneal haze, two in each group, even if none needed a transplant. (pubmed.ncbi.nlm.nih.gov) ### Is this the only way to treat ultrathin corneas? No — and that is important context. Thin-cornea cross-linking is now a whole mini-field. Surgeons have explored contact lens-assisted methods and thickness-adjusted “sub400” protocols that change UV delivery based on stromal pachymetry. Healio covered one such protocol in 2024, with data in corneas as thin as 246 µm. So this new paper is less a one-off breakthrough than another piece of evidence that the old 400 µm wall is getting more flexible. (healio.com) ### What is the real takeaway? The big idea is simple — some patients once considered too thin for cross-linking may not be automatically excluded anymore. But this is still a tailored, surgeon-dependent decision, not a blanket rule. The bottom line is that thin corneas are moving from “untreatable by standard CXL” to “treatable with modified protocols,” and that is a meaningful shift for keratoconus care. (healio.com 1) (healio.com 2)